In this episode of ‘In conversation with’ we are interviewing dr. Amalia Campos Delgado about her research on migration and border control in Mexico. |
Zoekresultaat: 2 artikelen
Jaar 2020 xInterview |
In gesprek met dr. Amalia Campos Delgado |
Tijdschrift | Crimmigratie & Recht, Aflevering 2 2020 |
Auteurs | Maartje van der Woude |
SamenvattingAuteursinformatie |
Artikel |
Upperdogs Versus UnderdogsJudicial Review of Administrative Drug-Related Closures in the Netherlands |
Tijdschrift | Recht der Werkelijkheid, Aflevering 1 2020 |
Trefwoorden | Eviction, War on drugs, Party capability, Empirical legal research, Drug policy |
Auteurs | Mr. Michelle Bruijn en Dr. Michel Vols |
SamenvattingAuteursinformatie |
In the Netherlands, mayors are entitled to close public and non-public premises if drug-related activities are being conducted there. Using data from the case law of Dutch lower courts, published between 2008 and 2016, this article examines the relative success of different types of litigants, and the influence of case characteristics on drug-related closure cases. We build on Galanter’s framework of ‘repeat players’ and ‘one-shotters’, to argue that a mayor is the stronger party and is therefore more likely to win in court. We categorise mayors as ‘upperdogs’, and the opposing litigants as ‘underdogs’. Moreover, we distinguish stronger mayors from weaker ones, based on the population size of their municipality. Similarly, we distinguish the stronger underdogs from the weaker ones. Businesses and organisations are classified as stronger parties, relative to individuals, who are classified as weaker parties. In line with our hypothesis, we find that mayors win in the vast majority of cases. However, contrary to our presumptions, we find that mayors have a significantly lower chance of winning a case if they litigate against weak underdogs. When controlling for particular case characteristics, such as the type of drugs and invoked defences, our findings offer evidence that case characteristics are consequential for the resolution of drug-related closure cases in the Netherlands. |